GLP-2 levels and gut damage after belly or pelvic radiation
This study looks at how a natural gut hormone called GLP-2 changes in your blood after radiation treatment for cancer in the belly or pelvic area, and whether it relates to gut irritation (radiation enteritis). It may help doctors understand and better manage radiation side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have cancer and are scheduled to receive radiation to your belly or pelvic area.
- You do not have active gut inflammation or severe diarrhea before starting radiation.
- You are expected to complete the full radiation course and a 1-month follow-up visit.
- You are willing to provide blood samples and fill out questionnaires about your symptoms, nutrition, and quality of life.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether combining thalidomide and glutamine helps people with bleeding caused by past radiation treatment to the abdomen or pelvis. The medication may reduce inflammation and help healing.
This trial tests an oral probiotic (a mix of 5 good bacteria) to see if it can reduce stomach and bowel side effects from pelvic radiation. It may help people undergoing radiation for certain pelvic cancers.
This study examines blood and tissue markers that show how radiation therapy affects the intestines during cancer treatment. The goal is to better understand and predict intestinal damage so doctors can prevent or treat it more effectively.
This study tests if a traditional Chinese medicine formula (Gegen Qinlian Tang) plus probiotics can help people who have gut problems from radiation treatment for cancer. It may reduce diarrhea, pain, or other bowel symptoms caused by radiation.
This study explores why some patients develop bladder problems after receiving high-dose radiation to the abdomen. Researchers will collect samples to identify warning signs (biomarkers) that might predict or detect these changes early.
This trial tests whether a Bergmann enema can help prevent radiation-related rectal injury during short-course radiotherapy for rectal cancer. It may be an option for people who are about to start pelvic radiation.
Hear when a new Radiation Enteritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.